ProShare Advisors
CLMT icon

ProShare Advisors’s Calumet Specialty Products CLMT Stock Holding History

ProShare Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Sell
9,059
-938
-9% -$31.5K ﹤0.01% 1357
2026
Q1 		$359K Sell
9,997
-2,616
-21% -$67.7K ﹤0.01% 1241
2025
Q4 		$251K Buy
12,613
+817
+7% +$15.7K ﹤0.01% 1566
2025
Q3 		$215K Sell
11,796
-2,350
-17% -$38.7K ﹤0.01% 1659
2025
Q2 		$223K Buy
+14,146
New +$180K ﹤0.01% 1654

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ProShare Advisors's CLMT Position: Q2 2026 in Review

ProShare Advisors reduced its Calumet Specialty Products (CLMT) stake by 9.4% in Q2 2026, selling an estimated $31.5K and leaving 9,059 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #1357.

ProShare Advisors first reported a position in CLMT in Q2 2025 and has held it in 5 quarters since. The position peaked at $359K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • ProShare Advisors held 9,059 shares of Calumet Specialty Products worth $326K as of Q2 2026.
  • ProShare Advisors sold 938 Calumet Specialty Products shares in Q2 2026, an estimated $31.5K.
  • Calumet Specialty Products made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1357 holding.
  • ProShare Advisors first reported a position in Calumet Specialty Products in Q2 2025 and has held it in 5 quarters since.
  • ProShare Advisors's Calumet Specialty Products position peaked at $359K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.